Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00308581
Status:
COMPLETED
Last Update Posted:
2018-08-07
First Post:
2006-03-28
Brief Title:
Certolizumab in Crohns Disease Patients With Loss of Response or Intolerance to Infliximab
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
C87042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None